Hyperuricemia in patients with chronic plaque psoriasis - 18/12/13
, Giovanni Targher, MD b, Anna Cagalli, MD a, Giampiero Girolomoni, MD aAbstract |
Background |
Few studies have examined the association between elevated serum uric acid (SUA) levels and psoriasis, and their results have been inconclusive because most of these studies did not take into account the confounding effects of coexisting features of the metabolic syndrome.
Objective |
We compared the prevalence of hyperuricemia and SUA levels between psoriatic patients and control individuals.
Methods |
Levels of SUA were measured in 119 consecutive psoriatic patients and 119 control individuals matched for age, sex, and body mass index.
Results |
Compared with control subjects, psoriatic patients had higher SUA levels (5.61 ± 1.6 vs 4.87 ± 1.4 mg/dL; P < .001) and a remarkably greater prevalence of asymptomatic hyperuricemia (19% vs 7%; P < .001). Multivariate logistic regression analysis revealed that psoriasis was the strongest predictor of hyperuricemia (odds ratio 3.20; 95% confidence interval 1.32-7.58; P < .01) after adjusting for age, sex, and metabolic syndrome features.
Limitations |
The cross-sectional design of this study does not allow us to draw any conclusion about a causal relation between psoriasis and hyperuricemia.
Conclusions |
Hyperuricemia is a common finding in psoriatic patients. Its treatment might be clinically useful for the global treatment of patients.
Le texte complet de cet article est disponible en PDF.Key words : body mass index, cardiovascular risk, hyperuricemia, psoriasis, psoriatic arthritis, uric acid
Abbreviations used : BMI, CVD, PASI, PsA, SUA
Plan
| Supported by the Ministero della Salute, and the Ministero dell’Istruzione, Università e Ricerca Scientifica (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale), and by the Association for Dermatological Research. |
|
| Conflicts of interest: None declared. |
|
| Reprints not available from the authors. |
Vol 70 - N° 1
P. 127-130 - janvier 2014 Retour au numéro
Article précédent
- Clinical and cytologic features of antibiotic-resistant acute paronychia
- Murat Durdu, Vincenzo Ruocco
- The MPATH-Dx reporting schema for melanocytic proliferations and melanoma
- Michael W. Piepkorn, Raymond L. Barnhill, David E. Elder, Stevan R. Knezevich, Patricia A. Carney, Lisa M. Reisch, Joann G. Elmore
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?